Insights

Gathering insights about FCS…

Similar companies to FCS

FCS Tech Stack

FCS uses 8 technology products and services including RSS, MySQL, SendGrid, and more. Explore FCS's tech stack below.

RSS
Content Management System
MySQL
Database
SendGrid
Email Delivery
JSZip
Javascript Libraries
pdfmake
Javascript Libraries
DataTables
Javascript Libraries
Windows Server
Operating Systems
Ookla Speedtest Custom
Widgets

Media & News

Arrowhead Pharmaceuticals Announces FDA Approval of REDEMPLO® (plozasiran) to Reduce Triglycerides in Adults with Familial Chylomicronemia Syndrome (FCS)
PASADENA, Calif.--(BUSINESS WIRE)---- $arwr--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that the U.S. Food and Drug Administration (FDA) has approved REDEMPLO (plozasiran), a small interfering RNA (siRNA) medicine, as an adjunct to diet to reduce triglycerides in adults with familial chylomicronemia syndrome (FCS). FCS is a severe, rare disease, with an estimated 6,500 people in the U.S. living with genetic or clinical FCS, characterized by triglyceride levels that can be 10 to 100 ti.
Nov 18, 2025 | www.businesswire.com
TRYNGOLZA® (olezarsen) approved in the European Union for familial chylomicronemia syndrome (FCS)
CARLSBAD, Calif.--(BUSINESS WIRE)--Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) and Sobi® today announced that TRYNGOLZA® (olezarsen) has been approved in the European Union (EU) as an adjunct to diet in adult patients for the treatment of genetically confirmed familial chylomicronemia syndrome (FCS). The approval follows the positive opinion of the Committee for Medicinal Products for Human Use. The approval is based on positive data from the Phase 3 Balance study, in which TRYNGOLZA 80 mg demon.
Sep 19, 2025 | www.businesswire.com
TRYNGOLZA® (olezarsen) recommended for approval in the EU by CHMP for familial chylomicronemia syndrome (FCS)
CARLSBAD, Calif.--(BUSINESS WIRE)--Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) and Sobi® today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has adopted a positive opinion of TRYNGOLZA® (olezarsen) as an adjunct to diet in adult patients for the treatment of genetically confirmed familial chylomicronemia syndrome (FCS). The positive opinion is now referred to the European Commission (EC) for an approval decision, which is expected by Q4.
Jul 25, 2025 | www.businesswire.com
Arrowhead Pharmaceuticals Launches on Rare Disease Day New Patient-Centric Resources for Those Affected by Familial Chylomicronemia Syndrome (FCS)
PASADENA, Calif.--(BUSINESS WIRE)---- $arwr--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) marks Rare Disease Day with the expansion of the We'll Get There Soon campaign, initially launched for healthcare providers in November 2024. This new phase introduces a dedicated educational website, www.LowerMyTGs.com, and the Spotlight on FCS white paper, which provides essential resources and support for those affected by Familial Chylomicronemia Syndrome (FCS). FCS is an ultra-rare genetic disorder that signi.
Feb 28, 2025 | www.businesswire.com
Ionis Pharmaceuticals: Promising Growth From Tryngolza Approval
Ionis Pharmaceuticals applies proprietary antisense technology to tackle diseases at their genetic source, focusing on conditions such as FCS, Angelman syndrome, and HAE. The FDA approval of Tryngolza for FCS positions Ionis as the first company to independently develop and launch an RNA-targeted therapy. Ionis forecasts that its pipeline, containing approximately 40 investigational drugs, could generate billions in peak sales, with four launches projected in the next three years.
Dec 23, 2024 | seekingalpha.com
Bowman Acquires Utility Services and Sustainability Solutions Firm FCS Group
RESTON, Va.--(BUSINESS WIRE)--Bowman Consulting Group Ltd. (the “Company” or “Bowman”) (NASDAQ: BWMN), a national engineering services firm delivering infrastructure design solutions to customers who own, develop, and maintain the built environment, today announced the acquisition of Redmond, Washington based FCS Group (“FCS”). FCS is a professional services firm focused on addressing the financial, management and economic challenges facing public sector entities including utilities, state and.
Jul 18, 2024 | www.businesswire.com
Ionis announces olezarsen FCS New Drug Application accepted for Priority Review and enrollment in Phase 3 sHTG program completed
– Olezarsen PDUFA date set for December 19, 2024 for treatment of familial chylomicronemia syndrome – – Phase 3 enrollment completed in CORE, CORE2 and ESSENCE evaluating olezarsen for the treatment of severe hypertriglyceridemia, with results expected in 2H 2025 – CARLSBAD, Calif. , June 25, 2024 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the New Drug Application (NDA) for olezarsen, an investigational RNA-targeted medicine for the treatment of adults with familial chylomicronemia syndrome (FCS).
Jun 25, 2024 | www.prnewswire.com

FCS's Email Address Formats

FCS uses at least 1 format(s):

FCS Email Formats	Example	Percentage
First.Last@fcscommunications.com	John.Doe@fcscommunications.com	50%
Last@fcscommunications.com	Doe@fcscommunications.com	17%
FLast@fcscommunications.com	JDoe@fcscommunications.com	16%
FirstL@fcscommunications.com	JohnD@fcscommunications.com	17%

Frequently Asked Questions

What is FCS's phone number?

You can contact FCS's main corporate office by phone at

+1-972-521-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is FCS's stock symbol?

FCS is a publicly traded company; the company's stock symbol is FCS.

What is FCS's official website and social media links?

FCS's official website is fcscommunications.com and has social profiles on LinkedIn.

How much revenue does FCS generate?

As of December 2025, FCS's annual revenue is estimated to be $5M.

What is FCS's SIC code NAICS code?

FCS's SIC code is 2675 - Die-Cut Paper and Paperboard and Cardboard NAICS code is 5415 - Computer Systems Design and Related Services.

How many employees does FCS have currently?

As of December 2025, FCS has approximately 60 employees across 5 continents, including North AmericaAsiaAfrica. Key team members include Chief Executive Officer: R. B.Chief Quality Officer: L. E.President & Managing Partner: C. K.. Explore FCS's employee directory with LeadIQ.

What industry does FCS belong to?

FCS operates in the IT Services and IT Consulting industry.

What technology does FCS use?

FCS's tech stack includes RSSMySQLSendGridJSZippdfmakeDataTablesWindows ServerOokla Speedtest Custom.

What is FCS's email format?

FCS's email format typically follows the pattern of First.Last@fcscommunications.com. Find more FCS email formats with LeadIQ.

When was FCS founded?

FCS was founded in 2011.

FCS

Q: What is FCS's official website and social media links?

FCS's official website is fcscommunications.com. FCS has social profiles on LinkedIn.

Q: How many employees does FCS have currently?

FCS has approximately 60 employees.

Q: What technology does FCS use?

FCS's tech stack includes WordPress, Windows Server, Ookla Speedtest Custom, MySQL, Font Awesome.

IT Services and IT ConsultingTexas, United States51-200 Employees

As trusted advisors, FCS brings over 30 years of industry experience along with our strategic partners to help you navigate through the IT fog. At FCS, our main focus is “The Customer Experience”. Our solutions allow customers access to innovative tools so they can perform their jobs more efficiently, focus on maximizing business growth and improve overall productivity.

FCS aspires to be an extension to every company’s IT department. Through our holistic and diversified approach, we have the ability to better understand our customers needs and execute based on requirements.